About Actipulse Neuroscience
Actipulse Neuroscience is a company based in Cambridge (United States) founded in 2017 by Adrien Chatillon and Gabriel Villafuerte. Actipulse Neuroscience has raised $125 thousand across 3 funding rounds from investors including Y Combinator, MassChallenge and Start-Up Chile. Actipulse Neuroscience operates in a competitive market with competitors including Newronika, NovaVision, MindAffect, EnClear Therapies and AccuMedical, among others.
- Headquarter Cambridge, United States
- Founders Adrien Chatillon, Gabriel Villafuerte
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Actipulse Neuroscience, Inc.
-
Annual Revenue
$173.96 K (USD)6568as on Dec 31, 2022
-
Net Profit
$9.31 K (USD)138as on Dec 31, 2022
-
EBITDA
Not available
-
Total Equity Funding
$125 K (USD)
in 3 rounds
-
Latest Funding Round
$125 K (USD), Seed
Jan 22, 2022
-
Investors
Y Combinator
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Actipulse Neuroscience
Unlock access to complete
Software Development Team
3 people
Leadership Team
1 people
Research Team
1 people
Almacenista Team
1 people
Unlock access to complete
Funding Insights of Actipulse Neuroscience
Actipulse Neuroscience has successfully raised a total of $125K across 3 strategic funding rounds. The most recent funding activity was a Seed round of $125 thousand completed in January 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Actipulse Neuroscience
Actipulse Neuroscience has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Y Combinator, MassChallenge and Start-Up Chile.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are accelerated via funding and educational programs.
|
Locked | Locked | Locked | |
|
Early-stage entrepreneurs are accelerated through MassChallenge's program.
|
Locked | Locked | Locked | |
|
Government-backed startup accelerator programs are operated in Chile.
|
Locked | Locked | Locked |
Investor details for Actipulse Neuroscience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Actipulse Neuroscience
Investment portfolio details for Actipulse Neuroscience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Actipulse Neuroscience
Detailed financials for Actipulse Neuroscience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Actipulse Neuroscience Comparisons
Peer comparison for Actipulse Neuroscience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Actipulse Neuroscience
Actipulse Neuroscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Newronika, NovaVision, MindAffect, EnClear Therapies and AccuMedical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Medical devices for neurodegenerative diseases are developed.
|
|
| Locked | Locked | Locked |
Non-invasive devices are developed for vision restoration in stroke survivors.
|
|
| Locked | Locked | Locked |
Brain-computer interface headsets are developed for patient communication.
|
|
| Locked | Locked | Locked |
Developer of device-based therapies to treat neurodegenerative disorders
|
|
| Locked | Locked | Locked |
Neurovascular interventional devices for neurological disorders are developed.
|
Detailed competitors of Actipulse Neuroscience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Actipulse Neuroscience
Complete news archive for Actipulse Neuroscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Actipulse Neuroscience
Actipulse Neuroscience was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Actipulse Neuroscience is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Adrien Chatillon is the current CEO of Actipulse Neuroscience. They have also founded this company.
Actipulse Neuroscience is a funded company, having raised a total of $125K across 3 funding rounds to date.
Annual revenue of Actipulse Neuroscience is $173.96K as on Dec 31, 2022.
Actipulse Neuroscience was founded in 2017 in Cambridge, United States, within the biotechnology sector. Non-invasive devices utilizing high-frequency magnetic pulses for transcranial neuromodulation are developed to address pathogenic mechanisms in neurodegenerative disorders. Combination therapies involving drugs and neuromodulation technology are also pursued. Operations focus on research and development of these medical technologies.
Actipulse Neuroscience's top competitors include Newronika, NovaVision and EnClear Therapies.
Actipulse Neuroscience has 3 investors. Key investors include Y Combinator, MassChallenge, and Start-Up Chile.